Axial spondyloarthritis
Not yet recruitingA study comparing bimekizumab and adalimumab for treating chest pain in patients with active axial spondyloarthritis who do not respond well to non-steroidal anti-inflammatory drugs.
A study comparing bimekizumab and adalimumab for treating chest pain in patients with active axial spondyloarthritis who do not respond well to non-steroidal anti-inflammatory drugs.
- Disease:Axial spondyloarthritis
- Substances:AdalimumabBimekizumab
France- Participants:18–64 years
- Substances:Adalimumab
- Sponsor:Centre Hospitalier Universitaire Rouen






